Hansen Medical, Inc.  

(Public, NASDAQ:HNSN)   Watch this stock  
Find more results for hnsn
0.00 (0.00%)
Feb 11 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 1.28 - 12.20
Open     -
Vol / Avg. 0.00/415,290.00
Mkt cap 46.62M
P/E     -
Div/yield     -
EPS -4.39
Shares 18.87M
Beta 0.64
Inst. own 34%
May 11, 2016
Hansen Medical Inc Annual Shareholders Meeting (Estimated) - 1:00PM EDT - Add to calendar
Feb 22, 2016
Q4 2015 Hansen Medical Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -321.30% -278.26%
Operating margin -279.58% -237.41%
EBITD margin - -224.31%
Return on average assets -68.53% -94.48%
Return on average equity -234.87% -440.22%
Employees 169 -
CDP Score - -


800 East Middlefield Road
United States - Map
+1-650-4045800 (Phone)
+1-650-4045901 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Hansen Medical, Inc. is engaged in the development and marketing of medical devices. The Company develops, manufactures and sells medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Its technology is used in medical procedures that are reliant upon tools like guide wires, catheters, sheaths, balloons and stents. Its products include Sensei Robotic Catheter System (Sensei system), Artisan Extend Control Catheter (Artisan catheter), CoHesion 3D Visualization Module and Magellan Robotic System. Its Hansen Medical Solution consists of two modules: a physician control console and a patient-side module that can be connected to procedure tables. Physicians sit at control console outside the radiation field and use hands to control and navigate disposable catheters, which are attached to the patient-side module. Its catheters deliver third-party catheters and catheter-based technologies to specific sites.

Officers and directors

Michael L. Eagle Lead Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Cary G. Vance President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Christopher P. Lowe Interim Chief Financial Officer, Director
Age: 48
Bio & Compensation  - Reuters
Robert O. Cathcart Senior Vice President - Global Sales
Age: 55
Bio & Compensation  - Reuters
Joseph James Guido Senior Vice President - Marketing and Business Development
Age: 49
Bio & Compensation  - Reuters
Brian Sheahan Vice President - Clinical, Regulatory & Quality Affairs
Age: 49
Bio & Compensation  - Reuters
Marjorie L. Bowen Independent Director
Age: 50
Bio & Compensation  - Reuters
Kevin Hykes Independent Director
Age: 49
Bio & Compensation  - Reuters
Stephen Newman M.D. Independent Director
Age: 64
Bio & Compensation  - Reuters
William R. Rohn Independent Director
Age: 71
Bio & Compensation  - Reuters